SK PHARMATECH SOLUTIONS PRIVATE LIMITED

About GSTIN 37ABICS9430N1ZM

SK PHARMATECH SOLUTIONS PRIVATE LIMITED is a Private Limited Company registered under GST in Andhra Pradesh with GSTIN 37ABICS9430N1ZM. The GST registration was obtained on 07 September 2022. The current status of this GST registration is .

The PAN associated with this GSTIN is ABICS9430N. The registration type is Regular. The primary nature of business activities is Others. This GST registration is linked to SK PHARMATECH SOLUTIONS PRIVATE LIMITED (CIN: U73100AP2022PTC122230).

GST Registration Details

GSTIN
37ABICS9430N1ZM
PAN Number
Legal Name
SK PHARMATECH SOLUTIONS PRIVATE LIMITED
Trade Name
Not Available
Status
GST Type
Regular
State / Jurisdiction
Andhra Pradesh (Code: 37)
Entity Type
Private Limited Company
Nature of Business
Others
Registration Date
07 Sep 2022
Principal Place of Business
1-53/7/1/4 SF302 SECOND FLOOR MVP Second Circle Visakhapatnam Andhra Pradesh

Linked Company Information

CIN
U73100AP2022PTC122230
Company Class
Private
Company Status
Active

Frequently Asked Questions

Is 37ABICS9430N1ZM a valid GST number?

Yes, 37ABICS9430N1ZM is a valid GSTIN registered under the Goods and Services Tax (GST) system in India. It belongs to SK PHARMATECH SOLUTIONS PRIVATE LIMITED in Andhra Pradesh. The current status of this registration is .

What is the legal name registered under 37ABICS9430N1ZM?

The legal name registered under GSTIN 37ABICS9430N1ZM is SK PHARMATECH SOLUTIONS PRIVATE LIMITED.

What is the PAN linked to 37ABICS9430N1ZM?

The PAN (Permanent Account Number) linked to GSTIN 37ABICS9430N1ZM is ABICS9430N. The first two digits of a GSTIN represent the state code (37 for Andhra Pradesh), followed by the 10-character PAN, an entity code, the letter 'Z', and a check digit.

Which company is 37ABICS9430N1ZM linked to?

GSTIN 37ABICS9430N1ZM is linked to SK PHARMATECH SOLUTIONS PRIVATE LIMITED (CIN: U73100AP2022PTC122230), a Private company registered in India.

Data last updated: 09 Feb 2026, 00:59 | Record updated: 09 Feb 2026